B- and T-cell acute lymphoblastic leukemias evade chemotherapy at distinct sites in the bone marrowMalwine J. Barz, Jean‐Pierre Bourquin, Lena Behrmann et al.|Haematologica|2022Cited by 12
Transcriptional remodeling shapes therapeutic vulnerability to necroptosis in acute lymphoblastic leukemiaAnna Saorin, Beat Bornhäuser, Anna Dehler et al.|Blood|2025Cited by 11
A three-dimensional ex vivo model recapitulates in vivo features and drug resistance phenotypes in childhood acute lymphoblastic leukemiaMagdalini Kanari, Jean‐Pierre Bourquin, Iria Jimenez Garcia et al.|Leukemia|2025Cited by 4
Drug Response Profiling Informs Personalized Bridging to Cell Therapy for Patients with Relapsed/Refractory Acute Lymphoblastic LeukemiaFabio D. Steffen, Jean‐Pierre Bourquin, Andrej Lissat et al.|Blood|2023Cited by 1
Phenotypic Drug Response Profiling Identifies Asparaginase-Based Synergistic Combinations for Very High Risk Acute Lymphoblastic LeukaemiaJasmeet Sidhu, Jean‐Pierre Bourquin, Fabio D. Steffen et al.|Blood|2023Cited by 1